The MHRA regulates the approval of new medicines in Great Britain following the UK's departure from the European Union, whilst the EMA retains responsibility for authorisation across EU member states
Retatrutide Dosing Based on Phase 2 trial escalation schedules, a gradual titration is recommended to minimize gastrointestinal side effects
Pricing Structure (per company website): First month: $249.97 Subsequent months: $349.97 per month Multi-month options: 3 months ($749.97), 6 months ($1,349.82), 12 months ($2,349.88) Similar to the semaglutide option, the platform states that dosage adjustments do not affect monthly pricing-you pay the same flat rate regardless of dose changes prescribed by your provider
Can higher doses always be expected to give better results
The bigger safety issue is that retatrutide is still being studied, so its long-term risks and final prescribing warnings are not fully defined
However, microdosing is typically considered to be safe as it involves very small or fractional doses of medications